Cytosorbents (CTSO) EBT Margin (2011 - 2026)
Cytosorbents (CTSO) reported EBT Margin of 44.01% for Q1 2026, down 2707.0% on a YoY basis from 1.69% in Q1 2025, and up 37.54% quarter-over-quarter from 70.46% in Q4 2025.
Cytosorbents (CTSO) EBT Margin (2011 - 2026) Analysis & Trends
Cytosorbents has reported EBT Margin for 16 years, with the latest figure at 44.01% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 2707.0% year-over-year to 44.01%; the trailing twelve-month figure through Mar 2026 stood at 48.95% (up 100.0% YoY), and the FY2025 full-year result was 25.92%, up 3703.0% from the prior year.
- EBT Margin for Q1 2026 stood at 44.01%, up from 70.46% in the prior quarter.
- The five-year high for EBT Margin was 167.57% in Q4 2023, with the low at 150.42% in Q3 2022.
- Historically, EBT Margin has averaged 55.41% across 5 years, with a median of 65.31% in 2023.
- Annual changes were most pronounced in 2023 — EBT Margin jumped 18736 bps — and 2024, when it tumbled 26874 bps.
- Cytosorbents' EBT Margin stood at 19.79% in 2022, then surged by 947 bps to 167.57% in 2023, then plunged by 160 bps to 101.17% in 2024, then jumped by 30 bps to 70.46% in 2025, then jumped by 38 bps to 44.01% in 2026.
- The last three EBT Margin figures came in at 44.01% (Q1 2026), 70.46% (Q4 2025), and 37.65% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.17% |
| 10 | Cytosorbents | 28.80 Mn | 24.00 Mn | 6.13 Mn | -44.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.01% |
| Dec 31, 2025 | -70.46% |
| Sep 30, 2025 | -37.65% |
| Jun 30, 2025 | -44.00% |
| Mar 31, 2025 | -16.94% |
| Dec 31, 2024 | -101.17% |
| Sep 30, 2024 | -32.14% |
| Jun 30, 2024 | -46.86% |
| Mar 31, 2024 | -67.73% |
| Dec 31, 2023 | 167.57% |
| Sep 30, 2023 | -104.34% |
| Jun 30, 2023 | -65.31% |
| Mar 31, 2023 | -77.53% |
| Dec 31, 2022 | -19.79% |
| Sep 30, 2022 | -150.42% |
| Jun 30, 2022 | -128.06% |
| Mar 31, 2022 | -103.16% |
| Dec 31, 2021 | -93.14% |
| Sep 30, 2021 | -65.64% |
| Jun 30, 2021 | -38.90% |